Kallioniemi, Olli
Science for Life Laboratory,
Sweden
2024 Rank: 100470
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3311 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100470 | 105665 |
| Total Cites | 1541 | 1708 |
| H-index | 16 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 19 | 19 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 305 | 331 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1409 | 1503 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.14 |
| Self-Citation Percentage |
9.78%
|
|
Kallioniemi, Olli
Helsingin Yliopisto,
Finland
2023 Rank: 77836
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2822 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77836 | 86782 |
| Total Cites | 1730 | 1938 |
| H-index | 19 | 19 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 23 | 23 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 311 | 338 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1573 | 1702 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
10.73%
|
|
Kallioniemi, Olli
Helsingin Yliopisto,
Finland
2021 Rank: 53549
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1926 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53549 | 59346 |
| Total Cites | 2970 | 3346 |
| H-index | 26 | 26 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 57 | 58 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 597 | 649 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2723 | 2963 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.13 |
| Self-Citation Percentage |
11.24%
|
|
Kallioniemi, Olli
Helsingin Yliopisto,
Finland
2020 Rank: 46933
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 1652 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46933 | 50321 |
| Total Cites | 2445 | 2750 |
| H-index | 24 | 25 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 53 | 53 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 508 | 550 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2221 | 2416 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
11.09%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.